John C. Cambier
8Patents
4h-index
8Co-inventors
50Inventor score
Filing activity: Feb 25, 2000 → Oct 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9150831B2 | Conditionally immortalized long-term stem cells and methods of making and using such cells | Chemistry; Metallurgy | 15 | Active |
| US7825224B2 | Product and method for treatment of conditions associated with receptor-desensitization | Chemistry; Metallurgy | 9 | Active |
| US6503509B1 | Method for receptor desensitization | Chemistry; Metallurgy | 7 | Expired |
| US10760055B2 | Conditionally immortalized long-term stem cells and methods of making and using such cells | Chemistry; Metallurgy | 6 | Active |
| US8883507B2 | Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells | Chemistry; Metallurgy | 1 | Active |
| US11701361B2 | p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an immune response to exogenous immunogens | Human Necessities | 0 | Active |
| US9796961B2 | Conditionally immortalized long-term stem cells and methods of making and using such cells | Chemistry; Metallurgy | 0 | Active |
| US11078276B2 | Anti-CD79 antibodies and their uses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.